Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma

European Journal of Cancer

Volumn 35, Issue 1, 1999, Pages 133-137

  Tomisawa, M ^a   Tokunaga, T ^a   Oshika, Y ^a   Tsuchida, T ^a   Fukushima, Y ^a   Sato, H ^b   Kijima, H ^a   Yamazaki, H ^a   Ueyama, Y ^a   Tamaoki, N ^a   Nakamura, M ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; MRNA isoform; Renal cell carcinoma; Vascular endothelial growth factor; Vascularisation

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

BLOTTING, NORTHERN; CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, NEOPLASM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033061154     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00278-0     Document Type: Article

References (28)

1. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246, 1309-1312.
2. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
3. Senger D.R., Galli S.J., Dvorak A.M., Peruzzi C.A., Harvey V.S., Dvorak H.F. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
4. Berse B., Brown L.F., Vav De Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumours. Mol Biol Cell. 3:1992;211-220.
5. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 5:1991;1806-1814.
6. Park J, Keller G-A, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential disposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993, 4, 1317-1326.
7. Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 267:1992;26031-26037.
8. Cohen T, Gitay-Goren H, Sharon R, et al. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparin sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 1995, 270, 11322-11326.
9. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1995;1029-1038.
10. Plouet J, Moro F, Bertagnoli S, et al. Extracellular cleavage of the vascular endothelial growth factor 189- amino acid form by urokinase is required for its mitogenic effects. J Biol Chem 1997, 272, 13390-13396.
11. Tokunaga T, Oshika Y, Abe Y, et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 1998, 77, 998-1002.
12. Berkman RA, Merril MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth gene in central nervous system neoplasms. J Clin Invest 1993, 91, 153-159.
13. Suzuki K, Hayashi N, Miyamoto Y, et al. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 1996, 56, 3004-3009.
14. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma. Am J Pathol 1993, 143, 1255-1262.
15. Takahashi A, Sasaki H, Kim SJ, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994, 54, 4233-4237.
16. Nicol D, Hii SI, Walsh M, et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol 1997, 157, 1482-1486.
17. Sambrook J, Fritsh EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989, 7.
18. Oshika Y, Nakamura M, Tokunaga T, et al. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 1998, 12, 541-544.
19. Takahashi Y, Kitadai Y, Bucana CD, Cleary RK, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995, 55, 3964-3968.
20. Delahunt B., Bethwaite P., Nacey J.N. Renal cell carcinoma in New Zealand: a national survival study. Urology. 43:1994;300-309.
21. Jakobsen E.B., Eickhoff J.H., Andersen J.P., Ottesen M. Prognosis after nephrectomy for renal cell carcinoma. Scand J Urol Nephrol. 28:1994;229-236.
22. Eskelinen M., Lipponen P., Aitto-Oja L., Hall O., Syrjanen K. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. Int J Cancer. 55:1993;547-554.
23. Graham C., Rivers J., Kerbel R., Stankiewicz K., White W. Extent of vascularisation as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol. 145:1994;510-514.
24. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
25. Weidner N., Carro P.R., Flax J., Blumenfeld W., Folkman J. Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
26. Maeda K, Chung YS, Takatsuka S, et al. Tumour angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995, 13, 477-481.
27. Tokunaga T., Nakamura M., Oshika Y., Ohnishi Y., Ueyama Y. Is xenotransplantability of human colon cancers in SCID mice affected by angiogenic factors? J Natl Cancer Inst. 90:1998;400-401.
28. Koura A.N., Liu W., Kitadai Y., Singh R.K., Radinsky R., Ellis M.L. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res. 56:1996;3891-3894.